Amato Antonio, Cappabianca Maria Pia, Perri Maria, Zaghis Ivo, Mastropietro Fabrizio, Ponzini Donatella, Di Biagio Paola, Piscitelli Roberta
Associazione Nazionale lotta contro Microcitemie in Italia (ANMI Onlus), Centro Studi Microcitemie, Roma, Italia.
Hemoglobin. 2012;36(5):480-4. doi: 10.3109/03630269.2012.718309.
We report a novel frameshift mutation in exon 3 of the β-globin gene, that, in the heterozygous state, leads to a β-thalassemia intermedia (β-TI) phenotype (marked anemia, splenomegaly, hyperbilirubinemia, jaundice, unbalanced synthesis of α/non-α chains in a 34-year-old Italian woman. This frameshift mutation, due to the deletion of the first nucleotide (-A) at codon 120, results in a β-globin chain that is elongated to 156 amino acid residues. These highly unstable abnormal chains precipitate in the erythroblasts as inclusion bodies, thus causing inefficient erythropoiesis and ultimately resulting in the observed dominant clinical phenotype.
我们报告了β-珠蛋白基因外显子3中的一种新型移码突变,在杂合状态下,该突变导致一名34岁意大利女性出现中间型β地中海贫血(β-TI)表型(明显贫血、脾肿大、高胆红素血症、黄疸、α/非α链合成失衡)。这种移码突变是由于密码子120处的第一个核苷酸(-A)缺失,导致β-珠蛋白链延长至156个氨基酸残基。这些高度不稳定的异常链在成红细胞中以包涵体形式沉淀,从而导致红细胞生成效率低下,并最终导致观察到的显性临床表型。